8 Best Small Cap Robotics Stocks to Buy According to Analysts

In this article, we will discuss the 8 Best Small Cap Robotics Stocks to Buy According to Analysts.

The robotics industry is experiencing rapid and broad-based growth, driven by accelerating interest in automation in manufacturing, logistics, healthcare, and service industries. Businesses are adopting robots to help them increase productivity, improve operational efficiency, and address labor shortages.

The industry is shifting from remote-controlled robots to autonomous, AI-powered systems that can learn, adapt, handle complex tasks, and operate alongside humans. Humanoid robots, the kind that look and act like humans, are particularly seeing a surging interest as businesses increasingly turn to these machines to address labor shortages and rising costs.

According to Morgan Stanley, the humanoid robots market size could exceed $5 trillion by 2050. By that time, the investment bank predicts there will be 1 billion humanoids in use globally.

Sidewalk delivery robots are also seeing growing interest in the food delivery industry, where they are deployed to cut logistic costs.

“Advances in brains, brawn, and batteries are pushing AI-enabled robotics to an inflection point, setting the investment agenda for the next decade,” said Barclays researcher Zornitsa Todorova, according to a Bloomberg report on February 17. Todorova is head of thematic fixed-income research at Barclays and led a team that produced a report on the outlook of humanoid robots.

With the surging interest in robots, companies have come up to build robotic systems that could handle any kind of task, from working on construction sites to preparing food and delivering packages.

With that background in mind, let’s explore some of the best small-cap robotics stocks to buy according to analysts.

8 Best Small Cap Robotics Stocks to Buy According to Analysts

Our Methodology

To select our 8 best small-cap robotics stocks to buy according to analysts, we used the Finviz stock screener, sifted through various ETFs, and scanned financial media reports to identify companies in the robotics industry. We focused on companies that build robots, provide components used in robotic systems, offer robots as a service, or develop AI/software platforms for autonomous robotic applications.

Next, we selected companies with a market cap of $2 billion or lower. We ended up with dozens of stocks in our initial list and applied additional filters to pick out the best. We looked for stocks with at least 30% upside potential and that are favored by hedge funds. The hedge fund data was sourced from Insider Monkey’s database as of Q4 2025. Finally, we ranked the stocks based on their price upside potential.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research shows we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

Best Small Cap Robotics Stocks to Buy According to Analysts

8. Ouster Inc (NASDAQ:OUST)

Market Cap: $1.87 Billion

Number of Hedge Fund Holders: 23

Upside Potential: 33.53%

Ouster Inc (NASDAQ:OUST) is one of the best small cap robotics stocks to buy according to analysts. Ouster stock has climbed around 25% in the past month and surged more than 130% over the past year. Northland sees the stock soaring higher from its current level.

On May 7, Northland reiterated its Outperform rating on Ouster stock with a price target of $38. The firm renewed its bullish view on Ouster following the company’s robust Q1 2026 results and product announcements.

Ouster reported its Q1 results on May 5. Revenue jumped 49% YoY to $49 million and exceeded the Street’s expectation of $46.15 million. The topline growth was supported by strong lidar sales. The company posted a loss per share of $0.28, which narrowed from a loss per share of $0.42 a year ago but missed the Street’s forecast of a loss per share of $0.12.

For Q2 2026, Ouster targets revenue in the band of $49.5 million to $52.5 million. This quarter will include a full period of Stereolabs operations. Ouster closed its acquisition of Stereolabs in February, adding a leader in AI vision and perception solutions.

Ouster also continues to strengthen its product portfolio with new launches. On May 4, it unveiled the Rev8 LIDAR platform that features native color capability. According to Northland, the Rev8 is an industry first. Ouster said dozens of companies in industries like robotics intend to adopt its Rev8 sensors in their products.

California-based Ouster Inc (NASDAQ:OUST) provides lidar sensors and perception software used in autonomous cars, robots, and drones. Its technology enables robots to see their surroundings and navigate safely. Ouster supplies customers in industries like last-mile delivery, warehouse automation, and mining.

7. Omnicell Inc (NASDAQ:OMCL)

Market Cap: $1.99 Billion

Number of Hedge Fund Holders: 19

Upside Potential: 36.65%

Omnicell Inc (NASDAQ:OMCL) is one of the best small cap robotics stocks to buy according to analysts. Omnicell stock has gained more than 20% in the past month and climbed around 70% over the past year to trade at around $44.

On April 29, KeyBanc lifted its price target on Omnicell shares to $70 from $60 while keeping an Overweight rating on the stock. KeyBanc’s new price target suggests nearly 60% upside for the stock. The firm cited Omnicell’s strong growth outlook for the target upgrade.

According to KeyBanc, there’s strong pipeline demand from Omnicell’s newly launched Titan XT cabinets. In light of this, the firm sees a multi-year growth runway ahead for the company.

In Q1 2026, Omnicell’s revenue rose 15% YoY to $310 million, topping the Street’s forecast of $304.01 million. The company said the topline growth was supported by strength in its connected devices, consumables, and technical services business lines. Omnicell posted adjusted EPS of $0.55, up from $0.26 a year ago and above the analysts’ estimate of $0.33.

Omnicell exited Q1 with $239 million in cash and cash equivalents and $350 million in availability borrowing under its revolving credit facility.

Looking ahead, Omnicell anticipates Q2 2026 revenue in the band of $307 million to $313 million. It expects full-year 2026 revenue between $1.22 billion and $1.26 billion.

Omnicell Inc (NASDAQ:OMCL), based in California, provides automated robots for pharmacy inventory management. Its robotic systems increase efficiency in the management of hospital pharmacies, improve patient safety, and reduce human error.

6. Procept Biorobotics Corp (NASDAQ:PRCT)

Market Cap: $1.39 Billion

Number of Hedge Fund Holders: 26

Upside Potential: 47.18%

Procept Biorobotics Corp (NASDAQ:PRCT) is one of the best small cap robotics stocks to buy according to analysts. The Street expects PRCT stock to pop 47% from its current level.

Procept Biorobotics Corp (NASDAQ:PRCT) released its Q1 2026 report on April 29. It delivered revenue of $83.1 million, which rose 20% YoY and surpassed analysts’ forecast of $80.5 million. The topline growth was driven by increased unit sales of the company’s robotic surgery system, known as Hydros. The company also recorded strong sales of handpieces and other consumables.

The US market contributes the bulk of Procept Biorobotics revenue, and the company recorded a 19% YoY increase in US sales in Q1, with US revenue reaching $72.0 million. However, international sales grew the fastest at 25% YoY.

Higher expenses tied to commercial expansions and product development led Procept Biorobotics to a wider Q1 loss. It posted a loss per share of $0.56, compared with a loss per share of $0.45 a year ago. Even with the loss, the company exited the quarter in a strong cash position, revealing $249 million of cash.

As Procept Biorobotics strengthens the capabilities of its Hydros robotic system and expands globally, the management predicts sustained growth and improved profitability. The company anticipates full-year 2026 revenue between $390 million and $410 million, reflecting a growth of around 27% to 33%.

Procept Biorobotics Corp (NASDAQ:PRCT) provides robotic systems used in surgical procedures. It has developed an AI-powered platform designed for use in prostate surgery. Founded in 2007, Procept Biorobotics is based in California.

While we acknowledge the potential of PRCT to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PRCT and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the 5 Best Small Cap Robotics Stocks to Buy According to Analysts.

Disclosure: None. Follow Insider Monkey on Google News.